Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Floppy iris syndrome associated with specific medication intake: A narrative review

M. Maluskova, A. Vidlar, K. Maresova, V. Lounova, M. Karhanova

. 2023 ; 167 (1) : 9-15. [pub] 20221004

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc23002207

Intraoperative floppy iris syndrome (IFIS) is a cataract surgery complication that remains a challenge for eye surgeons. It is caused by the antagonism of alfa-1-adrenergic receptors within the dilator muscle of the iris, thus preventing the iris from dilation during a cataract surgery. The long-term blocking alfa-1 adrenergic receptors by the chronic use of a number of systemic medications may lead to permanent anatomical atrophy of the dilator muscle of the iris. The most common drugs associated with the development of IFIS are tamsulosin and other alpha-1 adrenergic receptor antagonists prescribed to patients with low urinary tract symptoms (LUTS). There are other systemic medications that have been reported to have increased risk for IFIS. It is crucial for the ophthalmologist to identify the high-risk patients prone to develop IFIS. Its presence may complicate the course of cataract surgery, ultimately negatively affecting visual outcome. Cataract surgery should be performed by an experienced eye surgeon using alternative pharmacological and surgical techniques. Interdisciplinary cooperation is essential to mitigate potential complications. Patients should be informed by their physicians about the need to report a medication history to their eye specialists, especially before cataract surgery.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002207
003      
CZ-PrNML
005      
20230517134552.0
007      
ta
008      
230406s2023 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2022.042 $2 doi
035    __
$a (PubMed)36196652
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Malušková, Miroslava $u Department of Ophthalmology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $u Department of Ophthalmology, University Hospital Olomouc, Czech Republic $7 xx0280061
245    10
$a Floppy iris syndrome associated with specific medication intake: A narrative review / $c M. Maluskova, A. Vidlar, K. Maresova, V. Lounova, M. Karhanova
520    9_
$a Intraoperative floppy iris syndrome (IFIS) is a cataract surgery complication that remains a challenge for eye surgeons. It is caused by the antagonism of alfa-1-adrenergic receptors within the dilator muscle of the iris, thus preventing the iris from dilation during a cataract surgery. The long-term blocking alfa-1 adrenergic receptors by the chronic use of a number of systemic medications may lead to permanent anatomical atrophy of the dilator muscle of the iris. The most common drugs associated with the development of IFIS are tamsulosin and other alpha-1 adrenergic receptor antagonists prescribed to patients with low urinary tract symptoms (LUTS). There are other systemic medications that have been reported to have increased risk for IFIS. It is crucial for the ophthalmologist to identify the high-risk patients prone to develop IFIS. Its presence may complicate the course of cataract surgery, ultimately negatively affecting visual outcome. Cataract surgery should be performed by an experienced eye surgeon using alternative pharmacological and surgical techniques. Interdisciplinary cooperation is essential to mitigate potential complications. Patients should be informed by their physicians about the need to report a medication history to their eye specialists, especially before cataract surgery.
650    _2
$a lidé $7 D006801
650    _2
$a alfa blokátory $x škodlivé účinky $7 D000317
650    _2
$a sulfonamidy $x škodlivé účinky $7 D013449
650    _2
$a iris $7 D007498
650    12
$a nemoci duhovky $x chemicky indukované $x diagnóza $7 D007499
650    _2
$a peroperační komplikace $x chemicky indukované $7 D007431
650    _2
$a syndrom $7 D013577
650    _2
$a adrenergní receptory $7 D011941
650    12
$a katarakta $x chemicky indukované $7 D002386
650    12
$a fakoemulzifikace $7 D018918
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Vidlář, Aleš, $u Department of Urology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $u Department of Urology, University Hospital Olomouc, Czech Republic $d 1974- $7 xx0082202
700    1_
$a Marešová, Klára $u Department of Ophthalmology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $u Department of Ophthalmology, University Hospital Olomouc, Czech Republic $7 nlk20060174069
700    1_
$a Lounová, Veronika $u Department of Urology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $u Department of Urology, University Hospital Olomouc, Czech Republic $7 xx0271091
700    1_
$a Karhanová, Marta $u Department of Ophthalmology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $u Department of Ophthalmology, University Hospital Olomouc, Czech Republic $7 xx0170144
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 167, č. 1 (2023), s. 9-15
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36196652 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20230406 $b ABA008
991    __
$a 20230517134547 $b ABA008
999    __
$a ok $b bmc $g 1933535 $s 1188413
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 167 $c 1 $d 9-15 $e 20221004 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK198 $a Pubmed-20230406

Najít záznam

Citační ukazatele

Možnosti archivace